Actively Recruiting

All Genders
NCT04919538

Longitudinal Study for Relapsing Polychondritis

Led by University of Pennsylvania · Updated on 2026-01-23

100

Participants Needed

1

Research Sites

461 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Relapsing polychondritis (RP) is a rare systemic inflammatory disease characterized by recurrent inflammation of cartilage including ears, nose, tracheobronchial tree, chest wall and joints. Less commonly, it can cause inflammation of eyes, vasculature, nervous system, skin and inner ear. The purpose of this study is to study the pathogenesis of RP.

CONDITIONS

Official Title

Longitudinal Study for Relapsing Polychondritis

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Any subject considered to have a diagnosis of relapsing polychondritis according to the investigator.
Not Eligible

You will not qualify if you...

  • Inability to provide consent, or in the case of minors, assent.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Pennsylvania

Philadelphia, Pennsylvania, United States, 19104

Actively Recruiting

Loading map...

Research Team

C

Carol McAlear

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here